Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-040-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Fully reported guideline study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 001
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Principles of method if other than guideline:
- The study (exposure technology) was performed according to OPPTS guideline 870.1300 as far as applicable to this particular study. The OPPTS guideline 870.5.395 was used for the evaluation in the bone marrow micronucleus assay. It meets also OECD Guideline 474.
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 4,4'-methylenediphenyl diisocyanate
- EC Number:
- 202-966-0
- EC Name:
- 4,4'-methylenediphenyl diisocyanate
- Cas Number:
- 101-68-8
- Molecular formula:
- C15H10N2O2
- IUPAC Name:
- 1,1'-methylenebis(4-isocyanatobenzene)
- Reference substance name:
- benzene, 1,1'- methylenebis[4-isocyanato-
- IUPAC Name:
- benzene, 1,1'- methylenebis[4-isocyanato-
- Details on test material:
- 99% pure;
re-analysis by Bayer AG at the end of the study: 4,4'-MDI: 99%; 2,4'-MDI: 0/98%; 2,2'-MDI:<0.01%; phenyl isocyanate: <1 ppm, stabiliser (BHT): 1060 ppm
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Brown Norway
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Age at study initiation: animals were approx. 2 months old
Weight: the variation of individual weights did not exceed +/- 10% of the mean.
Administration / exposure
- Route of administration:
- inhalation
- Details on exposure:
- MODE OF EXPOSURE: inhalation; were either exposed whole-body to conditioned air (negative control) or respirable MDI-aerosol at actual breathing zone concentrations of 9.2+/- 1.5 and 118 +/-8.6 mg/m3. One additional group of rats was exposed to 110 +/- 14.4 mg/m3 using a directed-flow nose-only mode of exposure utilizing a more refined aerosol generation technology.
AEROSOL GENERATION: In whole-body exposed rats the principles of aerosol generation used by Siegel (1999) were duplicated (MDI condensation aerosol formed by bubbling air through an impinger containing MDI monomer at 125°C) whilst in the nose-only exposed group a combined dispersion-condensation aerosol principle was devised (dispersion aerosol from heated MDI @80°C and evaporation/re-condensation under controlled conditions). In whole body exposed rats the mean mass median aerodynamic diameter (MMAD) was in the range of 2.4 - 3.1 gm (GSD 1.6) whereas in nose-only exposed rats it was 1.2 gm (GSD 1.5). In addition to gravimetric analyses, the nitro-reagent and the modified Marcali methods were used to characterize exposure atmospheres. Though both methods showed somewhat lower concentrations when compared to the gravimetric methods, it does neither appear that the principle of aerosol generation nor that the different humidity (whole-body: ab. 40%, nose-only: ab. 5%) appeared to have any impact on the chemical stability of airborne MDI.
SAMPLING TIME: Bone marrow smears were prepared from rats sacrificed 1, 2 and 7 days after cessation of exposure. - Duration of treatment / exposure:
- 1 hr/day, 1 exposure per week, 3 consecutive weeks
- Frequency of treatment:
- one hour/day, one exposure per week on three consecutive weeks
- Post exposure period:
- IN-LIFE OBSERVATIONS: Body weights were recorded prior to exposure weekly, clinical signs before and after each exposure. Clinical signs on exposure-free days: once/day. Rectal temperature measurements: before, directly after, and approx. 2-hrs after cessation of each exposure.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
about 113 mg MDI/m3, 7 mg/M3-whole body. about 113 mg/MDI/m3 nose only mode of exposure
Basis:
- No. of animals per sex per dose:
- 4 groups of young adult male Brown-Norway rats (Strain: BN/RijHsd); 6 per serial sacrifice 1, 2 and 7 days after last treatment/exposure in all but in the negative control group (day 1 only)
- Positive control(s):
- a) for clastogenic effects; cyclophosphamide (20 mg/kg, gavage) b) for spindle Poison effects - Colcemid (4 mg/kg, i.p.) Negative control; Conditioned, dry filtered air (whole-body exposure)
Examinations
- Details of tissue and slide preparation:
- SACRIFICE: 24, 48 hours and one week after last exposure (pentobarbital anesthesia).
TISSUE PREPARATION: Bone marrow from femur by aspiration with fetal bovine serum (FBS-solution); 5 replicate slides/animal were prepared and allowed to dry overnight. The slides were fixed with absolute methanol for 5 minutes. After completion of the in-live phase of study the slides were shipped to Dr. Bhaskar Gollapudi for staining and evaluation.
CELL STAINING: Acridine Orange and Wright-Giemsa (from duplicate slides) SCORING: 200 erythrocytes for PCE:NCE per animal and 2000 PCE per animal (coded and blind), Mast cells: 1000 nucleated cells per animal for determining the mast cell incidence.
FIXATION AND WEIGHT OF LUNGS: Lungs were fixed by instillation of formaldehyde fixative and stored in the same fixative for possible future histopathological examination. Prior to fixation, after exsanguination of rats the lung weights were determined. - Statistics:
- One-way ANOVA with Tukey post-hoc test following arcsine-square root transformation, if necessary to achieve normal distribution of data
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
Any other information on results incl. tables
- All rats exposed to 0 (air) and 9.2 mg MDI/m3 tolerated the whole-body exposure without specific signs whilst the 118 and 110 mg MDI/m3-exposed rats experienced labored and irregular breathing patterns, bradypnea and a serous nasal discharge. Mortality did not occur in any group. Apart from the 'irregular breathing pattern' both the incidence and intensity of clinical findings were almost identical in whole-body and nose-only exposed rats. The signs observed were related to respiratory tract irritation.
- Comparisons of control and MDI-exposed rats did not reveal any statistically significant effect on body weights, though there was a tendency of slightly decreased body weight gains in nose-only exposed rats.
- Statistical analysis of measurements of rectal temperatures revealed a significant hypothermia in the nose-only exposed rats.
- in nose-only exposed rats, lung weights were increased to a greater extent than in the in whole-body exposed rats. These findings are taken as indirect evidence that the nose-only mode of exposure provides a more rigorous means the expose rats to MDI. In whole-body exposed rats measures were taken to prevent their huddling together or burying their noses into the fur of neighboring rats in order to minimize their exposure to irritant particulates. Nonetheless, the irritant-related, reflexively induced hypothermia, associated with elevated lung weights , was only discernible in nose-only exposed rats.
- At no time point was there evidence of any effect on the frequency of mast cells. The frequency of mast cells was low enough not to interfere with the outcome of test. Rats treated with the positive control substances displayed increased MN-PCE on sampling days 1 and 2, but not on day 7. At no time point there was any evidence of an effect on the frequency of MN-PCE in MDI-exposed animals. -No differences in outcome existed following staining with the DANN-specific Acridine -Orange or Wright-Giemsa. These results indicate that, under the experimental conditions used, aerosolized MDI did not induce cytogenetic damage in vivo.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Of the authors: this study did not demonstrate any gentoxic (clastogenic) activity of aerosolized, inhaled MDI at concentrations as high as 118 mg/M3 air.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live1